Literature DB >> 27271569

Constitutive Lck Activity Drives Sensitivity Differences between CD8+ Memory T Cell Subsets.

Duane Moogk1, Shi Zhong1, Zhiya Yu2, Ivan Liadi3, William Rittase4, Victoria Fang5, Janna Dougherty1, Arianne Perez-Garcia1, Iman Osman6, Cheng Zhu4, Navin Varadarajan3, Nicholas P Restifo2, Alan B Frey7, Michelle Krogsgaard8.   

Abstract

CD8(+) T cells develop increased sensitivity following Ag experience, and differences in sensitivity exist between T cell memory subsets. How differential TCR signaling between memory subsets contributes to sensitivity differences is unclear. We show in mouse effector memory T cells (TEM) that >50% of lymphocyte-specific protein tyrosine kinase (Lck) exists in a constitutively active conformation, compared with <20% in central memory T cells (TCM). Immediately proximal to Lck signaling, we observed enhanced Zap-70 phosphorylation in TEM following TCR ligation compared with TCM Furthermore, we observed superior cytotoxic effector function in TEM compared with TCM, and we provide evidence that this results from a lower probability of TCM reaching threshold signaling owing to the decreased magnitude of TCR-proximal signaling. We provide evidence that the differences in Lck constitutive activity between CD8(+) TCM and TEM are due to differential regulation by SH2 domain-containing phosphatase-1 (Shp-1) and C-terminal Src kinase, and we use modeling of early TCR signaling to reveal the significance of these differences. We show that inhibition of Shp-1 results in increased constitutive Lck activity in TCM to levels similar to TEM, as well as increased cytotoxic effector function in TCM Collectively, this work demonstrates a role for constitutive Lck activity in controlling Ag sensitivity, and it suggests that differential activities of TCR-proximal signaling components may contribute to establishing the divergent effector properties of TCM and TEM. This work also identifies Shp-1 as a potential target to improve the cytotoxic effector functions of TCM for adoptive cell therapy applications.
Copyright © 2016 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27271569      PMCID: PMC4935560          DOI: 10.4049/jimmunol.1600178

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  71 in total

1.  Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells.

Authors:  C Yee; J A Thompson; D Byrd; S R Riddell; P Roche; E Celis; P D Greenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-11       Impact factor: 11.205

2.  T cell killing does not require the formation of a stable mature immunological synapse.

Authors:  Marco A Purbhoo; Darrell J Irvine; Johannes B Huppa; Mark M Davis
Journal:  Nat Immunol       Date:  2004-03-28       Impact factor: 25.606

3.  Antibody Fc engineering improves frequency and promotes kinetic boosting of serial killing mediated by NK cells.

Authors:  Gabrielle Romain; Vladimir Senyukov; Nicolas Rey-Villamizar; Amine Merouane; William Kelton; Ivan Liadi; Ankit Mahendra; Wissam Charab; George Georgiou; Badrinath Roysam; Dean A Lee; Navin Varadarajan
Journal:  Blood       Date:  2014-09-16       Impact factor: 22.113

4.  Transmembrane phosphoprotein Cbp regulates the activities of Src-family tyrosine kinases.

Authors:  M Kawabuchi; Y Satomi; T Takao; Y Shimonishi; S Nada; K Nagai; A Tarakhovsky; M Okada
Journal:  Nature       Date:  2000-04-27       Impact factor: 49.962

5.  Kinetic proofreading in T-cell receptor signal transduction.

Authors:  T W McKeithan
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-23       Impact factor: 11.205

Review 6.  SHP-1 and SHP-2 in T cells: two phosphatases functioning at many levels.

Authors:  Ulrike Lorenz
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

7.  Differential requirement for Lck during primary and memory CD8+ T cell responses.

Authors:  Kavita Tewari; Jane Walent; John Svaren; Rose Zamoyska; M Suresh
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-23       Impact factor: 11.205

Review 8.  Phenotypic models of T cell activation.

Authors:  Melissa Lever; Philip K Maini; P Anton van der Merwe; Omer Dushek
Journal:  Nat Rev Immunol       Date:  2014-09       Impact factor: 53.106

9.  Constitutively active Lck kinase in T cells drives antigen receptor signal transduction.

Authors:  Konstantina Nika; Cristiana Soldani; Mogjiborahman Salek; Wolfgang Paster; Adrian Gray; Ruth Etzensperger; Lars Fugger; Paolo Polzella; Vincenzo Cerundolo; Omer Dushek; Thomas Höfer; Antonella Viola; Oreste Acuto
Journal:  Immunity       Date:  2010-06-11       Impact factor: 31.745

10.  Small molecule inhibition of Csk alters affinity recognition by T cells.

Authors:  Boryana N Manz; Ying Xim Tan; Adam H Courtney; Florentine Rutaganira; Ed Palmer; Kevan M Shokat; Arthur Weiss
Journal:  Elife       Date:  2015-08-24       Impact factor: 8.140

View more
  8 in total

1.  A Phosphosite within the SH2 Domain of Lck Regulates Its Activation by CD45.

Authors:  Adam H Courtney; Jeanine F Amacher; Theresa A Kadlecek; Marianne N Mollenauer; Byron B Au-Yeung; John Kuriyan; Arthur Weiss
Journal:  Mol Cell       Date:  2017-07-20       Impact factor: 17.970

2.  Phosphoproteomic analysis of chimeric antigen receptor signaling reveals kinetic and quantitative differences that affect cell function.

Authors:  Alexander I Salter; Richard G Ivey; Jacob J Kennedy; Valentin Voillet; Anusha Rajan; Eva J Alderman; Uliana J Voytovich; Chenwei Lin; Daniel Sommermeyer; Lingfeng Liu; Jeffrey R Whiteaker; Raphael Gottardo; Amanda G Paulovich; Stanley R Riddell
Journal:  Sci Signal       Date:  2018-08-21       Impact factor: 8.192

3.  Conformational States Control Lck Switching between Free and Confined Diffusion Modes in T Cells.

Authors:  Geva Hilzenrat; Elvis Pandžić; Zhengmin Yang; Daniel J Nieves; Jesse Goyette; Jérémie Rossy; Yuanqing Ma; Katharina Gaus
Journal:  Biophys J       Date:  2020-02-11       Impact factor: 4.033

4.  The LCK-14-3-3ζ-TRPM8 axis regulates TRPM8 function/assembly and promotes pancreatic cancer malignancy.

Authors:  Yuan Huang; Shi Li; Qinfeng Liu; Zhijie Wang; Shunyao Li; Lei Liu; Weiwei Zhao; Kai Wang; Rui Zhang; Longfei Wang; Ming Wang; Declan William Ali; Marek Michalak; Xing-Zhen Chen; Cefan Zhou; Jingfeng Tang
Journal:  Cell Death Dis       Date:  2022-06-04       Impact factor: 9.685

5.  CD45 functions as a signaling gatekeeper in T cells.

Authors:  Adam H Courtney; Alexey A Shvets; Wen Lu; Gloria Griffante; Marianne Mollenauer; Veronika Horkova; Wan-Lin Lo; Steven Yu; Ondrej Stepanek; Arup K Chakraborty; Arthur Weiss
Journal:  Sci Signal       Date:  2019-10-22       Impact factor: 8.192

6.  Calibration of cell-intrinsic interleukin-2 response thresholds guides design of a regulatory T cell biased agonist.

Authors:  Caleb R Glassman; Leon Su; Sonia S Majri-Morrison; Hauke Winkelmann; Fei Mo; Peng Li; Magdiel Pérez-Cruz; Peggy P Ho; Ievgen Koliesnik; Nadine Nagy; Tereza Hnizdilova; Lora K Picton; Marek Kovar; Paul Bollyky; Lawrence Steinman; Everett Meyer; Jacob Piehler; Warren J Leonard; K Christopher Garcia
Journal:  Elife       Date:  2021-05-18       Impact factor: 8.140

Review 7.  Spatiotemporal Regulation of Signaling: Focus on T Cell Activation and the Immunological Synapse.

Authors:  Esther Garcia; Shehab Ismail
Journal:  Int J Mol Sci       Date:  2020-05-06       Impact factor: 5.923

8.  SIRPα Suppresses Response to Therapeutic Antibodies by Nurse Like Cells From Chronic Lymphocytic Leukemia Patients.

Authors:  Yu-Chen Enya Chen; Melinda Burgess; Sally Mapp; Peter Mollee; Devinder Gill; Antje Blumenthal; Nicholas A Saunders
Journal:  Front Immunol       Date:  2021-01-21       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.